REPLAGAL
We have a delivery model that reflects the different market dynamics of our two businesses, and helps us meet our patients’ needs more effectively.
REPLAGAL
Has had revenue growth of 22%.
“The constant pains I had are much better; it's wonderful to go through the day not dreading such pain.”
Mathieu Pauly
REPLAGAL replaces the enzyme which is missing or deficient in people suffering from Fabry disease. It's been shown to help improve both kidney function and heart size. For more information on Shire products visit http://www.shire.com/shire/products/
